KR-33426

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameKR-33426

Drug Alias NameBAFF inhibitors (Sejong University)KR-32673KR-33341KR-32592KR-33232 +[6]

ClassificationSmall molecules

Mechanisms of ActionB-cell-activating factor/B lymphocyte stimulator inhibitorsB-lymphocyte inhibitors

TargetsB-cell-activating factor/B lymphocyte stimulator

Therapy Area/IndicationsLupus Erythematosus, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSejong University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSejong University

Active IndicationsN/A

Inactive IndicationsLupus Erythematosus, Systemic

ATC CodeN/A